authors
- Stewart, S B
- Sarah P. Psutka MD MS
- Bergstralh, E J
- Rangel, L
- Karnes, R J
- Cheville, J C
- Sebo, T J
- Frank, I
- Boorjian, S A
- Thompson, R H
- Gettman, M T
- Tollefson, M K
- Umbriet, E C
Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2014
published in
has subject area
- Aged
- Androgen Antagonists
- Antineoplastic Agents, Hormonal
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Disease Progression
- Disease-Free Survival
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Grading
- Prognosis
- Proportional Hazards Models
- Prostatectomy
- Prostatic Neoplasms
- Retrospective Studies